Inactief instrument

Koers Neovasc Inc (US) Nasdaq

Aandelen

Duur

Periode

Stijl

The European Society of Cardiology Includes Neovasc Reducer™ for the Treatment of Refractory Angina in the European Practice Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes	03-09-19
Neovasc US : Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency	14-01-19

Sector